Singlera Genomics Inc.
PrivateLast Round
Strategic
Jul 4, 2024
Total Funding Raised
$296.7M
Company Overview
Singlera Genomics Inc. is a biotechnology company that develops and commercializes non-invasive genetic tests for early cancer screening, diagnosis, and prognostic monitoring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Singlera Genomics Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Singlera Genomics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jul 4, 2024 | ||||
| Series B Extension | Jun 8, 2022 | ||||
| Series B | Dec 15, 2020 | ||||
| Series A Extension | Mar 27, 2018 | ||||
| Series A | Aug 22, 2016 | ||||
Angel | Jul 1, 2014 |
Singlera Genomics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 德同资本 | Series B |
| FutureX Capital | Series B |
| Wuxi Capital Group Co.,Ltd | Series B |
| Jingxu Venture Capital | Series B, Series A Extension |
| Huamei International Investment Group | Series B |
| Lilly Asia Ventures | Series A Extension, Series A |
| Jointown Pharmaceutical Group | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 17, 2025
Partnering with the University of Pittsburgh for BT-Reveal test evaluation.
Singlera Genomics Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Singlera Genomics Inc.'s valuation, stock price, and market status.